Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene <i>NR3C1</i> Article Swipe
Christoph Heuck
,
Jackie Szymonifka
,
Emily Hansen
,
John D. Shaughnessy
,
Saad Z. Usmani
,
Frits van Rhee
,
Elias Anaissie
,
Bijay Nair
,
Sarah Waheed
,
Yazan Alsayed
,
Nathan Petty
,
Clyde Bailey
,
Joshua Epstein
,
Antje Hoering
,
John Crowley
,
Bart Barlogie
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22454726.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22454726.v1
PDF file, 56K, Salvage Regimen for 255 Patients with available data.
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22454726.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361909768
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361909768Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22454726.v1Digital Object Identifier
- Title
-
Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene <i>NR3C1</i>Work title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Christoph Heuck, Jackie Szymonifka, Emily Hansen, John D. Shaughnessy, Saad Z. Usmani, Frits van Rhee, Elias Anaissie, Bijay Nair, Sarah Waheed, Yazan Alsayed, Nathan Petty, Clyde Bailey, Joshua Epstein, Antje Hoering, John Crowley, Bart BarlogieList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22454726.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.22454726.v1Direct OA link when available
- Concepts
-
Thalidomide, Regimen, Multiple myeloma, Dexamethasone, Glucocorticoid, Glucocorticoid receptor, Cancer research, Table (database), Medicine, Internal medicine, Oncology, Computer science, Data miningTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361909768 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22454726.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.22454726.v1 |
| ids.openalex | https://openalex.org/W4361909768 |
| fwci | |
| type | supplementary-materials |
| title | Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene <i>NR3C1</i> |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10649 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9987999796867371 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Multiple Myeloma Research and Treatments |
| topics[1].id | https://openalex.org/T12534 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9643999934196472 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Protein Degradation and Inhibitors |
| topics[2].id | https://openalex.org/T11752 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9585999846458435 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Treatment and Pharmacology |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779609412 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6695551872253418 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q203174 |
| concepts[0].display_name | Thalidomide |
| concepts[1].id | https://openalex.org/C2781413609 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6245234608650208 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7308373 |
| concepts[1].display_name | Regimen |
| concepts[2].id | https://openalex.org/C2776364478 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6019101142883301 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q467635 |
| concepts[2].display_name | Multiple myeloma |
| concepts[3].id | https://openalex.org/C2780401358 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5521157383918762 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q422252 |
| concepts[3].display_name | Dexamethasone |
| concepts[4].id | https://openalex.org/C2780841215 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5519121885299683 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q422549 |
| concepts[4].display_name | Glucocorticoid |
| concepts[5].id | https://openalex.org/C59493245 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5449004769325256 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q14877410 |
| concepts[5].display_name | Glucocorticoid receptor |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.47627848386764526 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C45235069 |
| concepts[7].level | 2 |
| concepts[7].score | 0.43628403544425964 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q278425 |
| concepts[7].display_name | Table (database) |
| concepts[8].id | https://openalex.org/C71924100 |
| concepts[8].level | 0 |
| concepts[8].score | 0.42249277234077454 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[8].display_name | Medicine |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4168446362018585 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C143998085 |
| concepts[10].level | 1 |
| concepts[10].score | 0.3744957447052002 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[10].display_name | Oncology |
| concepts[11].id | https://openalex.org/C41008148 |
| concepts[11].level | 0 |
| concepts[11].score | 0.1263984739780426 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[11].display_name | Computer science |
| concepts[12].id | https://openalex.org/C124101348 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q172491 |
| concepts[12].display_name | Data mining |
| keywords[0].id | https://openalex.org/keywords/thalidomide |
| keywords[0].score | 0.6695551872253418 |
| keywords[0].display_name | Thalidomide |
| keywords[1].id | https://openalex.org/keywords/regimen |
| keywords[1].score | 0.6245234608650208 |
| keywords[1].display_name | Regimen |
| keywords[2].id | https://openalex.org/keywords/multiple-myeloma |
| keywords[2].score | 0.6019101142883301 |
| keywords[2].display_name | Multiple myeloma |
| keywords[3].id | https://openalex.org/keywords/dexamethasone |
| keywords[3].score | 0.5521157383918762 |
| keywords[3].display_name | Dexamethasone |
| keywords[4].id | https://openalex.org/keywords/glucocorticoid |
| keywords[4].score | 0.5519121885299683 |
| keywords[4].display_name | Glucocorticoid |
| keywords[5].id | https://openalex.org/keywords/glucocorticoid-receptor |
| keywords[5].score | 0.5449004769325256 |
| keywords[5].display_name | Glucocorticoid receptor |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.47627848386764526 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/table |
| keywords[7].score | 0.43628403544425964 |
| keywords[7].display_name | Table (database) |
| keywords[8].id | https://openalex.org/keywords/medicine |
| keywords[8].score | 0.42249277234077454 |
| keywords[8].display_name | Medicine |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.4168446362018585 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/oncology |
| keywords[10].score | 0.3744957447052002 |
| keywords[10].display_name | Oncology |
| keywords[11].id | https://openalex.org/keywords/computer-science |
| keywords[11].score | 0.1263984739780426 |
| keywords[11].display_name | Computer science |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22454726.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22454726.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22454726 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_Thalidomide_in_Total_Therapy_2_Overcomes_Inferior_Prognosis_of_Myeloma_with_Low_Expression_of_the_Glucocorticoid_Receptor_Gene_i_NR3C1_i_/22454726 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5085020317 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Christoph Heuck |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Christoph J. Heuck |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5061455388 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6114-6175 |
| authorships[1].author.display_name | Jackie Szymonifka |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jackie Szymonifka |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5002624425 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4733-3411 |
| authorships[2].author.display_name | Emily Hansen |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Emily Hansen |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5108204468 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | John D. Shaughnessy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | John D. Shaughnessy |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5009378735 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5484-8731 |
| authorships[4].author.display_name | Saad Z. Usmani |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Saad Z. Usmani |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5090044223 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9959-1282 |
| authorships[5].author.display_name | Frits van Rhee |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Frits van Rhee |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5108381242 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Elias Anaissie |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Elias Anaissie |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5112041795 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Bijay Nair |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Bijay Nair |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5111921085 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Sarah Waheed |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Sarah Waheed |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5110085052 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Yazan Alsayed |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yazan Alsayed |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5003642204 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Nathan Petty |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nathan Petty |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5108410805 |
| authorships[11].author.orcid | https://orcid.org/0009-0008-3694-0797 |
| authorships[11].author.display_name | Clyde Bailey |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Clyde Bailey |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5038021934 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-8553-1358 |
| authorships[12].author.display_name | Joshua Epstein |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Joshua Epstein |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5040237587 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4709-3027 |
| authorships[13].author.display_name | Antje Hoering |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Antje Hoering |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5109960637 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | John Crowley |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | John Crowley |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5000879635 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-6116-1017 |
| authorships[15].author.display_name | Bart Barlogie |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Bart Barlogie |
| authorships[15].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.22454726.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table 1 from Thalidomide in Total Therapy 2 Overcomes Inferior Prognosis of Myeloma with Low Expression of the Glucocorticoid Receptor Gene <i>NR3C1</i> |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10649 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9987999796867371 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Multiple Myeloma Research and Treatments |
| related_works | https://openalex.org/W2362389383, https://openalex.org/W2368327561, https://openalex.org/W2355234839, https://openalex.org/W2358193745, https://openalex.org/W2362120795, https://openalex.org/W2356511282, https://openalex.org/W1994721812, https://openalex.org/W2587346389, https://openalex.org/W1976805847, https://openalex.org/W1510880905 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.22454726.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22454726.v1 |
| primary_location.id | doi:10.1158/1078-0432.22454726.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22454726.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.255 | 6 |
| abstract_inverted_index.for | 5 |
| abstract_inverted_index.56K, | 2 |
| abstract_inverted_index.with | 8 |
| abstract_inverted_index.file, | 1 |
| abstract_inverted_index.Regimen | 4 |
| abstract_inverted_index.Salvage | 3 |
| abstract_inverted_index.Patients | 7 |
| abstract_inverted_index.available | 9 |
| abstract_inverted_index.<p>PDF | 0 |
| abstract_inverted_index.data.</p> | 10 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 16 |
| citation_normalized_percentile.value | 0.09817689 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |